Replies to post #30653 on Lexaria Bioscience Corp (LEXX)

[damAcon1]

No need to reopen the RS win/lose/net neutral debate.

The RS could be anywhere from a 1-2 to a 1-30 with an endgame of getting the stock to a $4 uplist price. Obviously hoping that news would be released potentially raising the stock to a price where it is not necessary.

I think the confusion is in the interpretation of the 1-30 RS. From your numbers you understood it as they will pick 1-30, regardless or current share price. I took it as, and I could be wrong but it is how I remember reading it, that they approved the range because the end goal was a $4 share price. Meaning, the 1-30 would only apply if the stock was 1333cents. In your 19cents example the RS would be around 1-21.

Anyway, my whole basis was off my interpretation of the RS. If no news is released...or (perceived) negative news (like Altria)...knowing the RS goal is to get the stock to $4, right now there is no catalyst. Therefore if someone firmly believe that a 1-30 is the endgame then any buy in above the 1-30, or .1333cent level, is a loss. Which could also explain the limited amount of buying at this level.

[Sanderson]

$19k investment, $5.7 sp after r/s. Ideal easy math situation. But in a few days shorts, MM, or whoever will walk this price down to $1.20 or lower. What uplisting are we talking about?